Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept vs Sulfasalazine in Early Axial Spondyloarthritis (ESTHER)
NCT00844142Phase 2Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2005
- Primary completion
- Jul 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in axial spondyloarthritis (axSpA), sponsored by Charité – Universitätsmedizin Berlin. Status: unknown.
02
Drugs
etanercept
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT00844142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00844142.